The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adjuvant immunotherapy following upfront surgery for stage II–III triple-negative breast cancer: A National Cancer Database Study.
 
Madison Canning
No Relationships to Disclose
 
Xiyuan (Angel) Ji
No Relationships to Disclose
 
Lan Lei
No Relationships to Disclose
 
Michael Schwartz
No Relationships to Disclose
 
Jeffrey Switchenko
No Relationships to Disclose
 
Manali Bhave
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Merck; Novartis; Novartis; Pfizer
 
Kevin Kalinsky
Employment - ADC Therapeutics (I); EQRx (I)
Stock and Other Ownership Interests - ADC Therapeutics (I); EQRx (I)
Consulting or Advisory Role - AstraZeneca; Bicycle Therapeutics; bioTheranostics; Cullinan Oncology; Daiichi Sankyo/Astra Zeneca; Genentech/Roche; Gilead Sciences; Lilly; Menarini Silicon Biosystems; Merck; Mersana; mersana; Novartis; Pfizer; ProteinQure; Puma Biotechnology; Regor; Relay Therapeutics
Research Funding - Ascentage Pharma (Inst); AstraZeneca (Inst); Daichi Sankyo (Inst); Genentech/Roche (Inst); Lilly (Inst); Novartis (Inst); Seagen (Inst)
 
Shipra Gandhi
Honoraria - Aptitude Health; Clinical Care Options; OncLive/MJH Life Sciences
Consulting or Advisory Role - AstraZeneca; Genentech; Hologic/Biotheranostics; MedPage Today; Novartis; Peerview; Stemline Therapeutics
Speakers' Bureau - Roche
Travel, Accommodations, Expenses - MJH Life Sciences; Roche